3rd party ad
SUPPORTERis ad-free.
Lazard Genetic Therapies ADR
Portfolio
Holdings
Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUTL.NASDAQ | Autolus Therapeutics Ltd | USA | Healthcare | Biotechnology | 2024-03-31 | 0 | 0.791 | 178.00 | $389.46 | $614.10 |
| |||||||||||||
PRQR.NASDAQ | ProQR Therapeutics BV | USA | Healthcare | Biotechnology | 2024-03-31 | 0 | 0.405 | 103.00 | $47.69 | $175.10 |
| |||||||||||||
SLN.NASDAQ | Silence Therapeutics PLC | USA | Healthcare | Biotechnology | 2024-03-31 | 0 | 1.347 | 36.00 | $122.47 | $655.56 |
|
Trades
Buys
Report date: 2023-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
SLN.NASDAQ | 36.00 | - | 264.61 | 5-11 | $18.21 | 276.2% |
Report date: 2023-03-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
PRQR.NASDAQ | 103.00 | - | 314.91 | 2-4 | $1.70 | -8.2% |
Adds
Report date: 2023-03-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
AUTL.NASDAQ | 124.00 | 229.6 | 242.40 | 2-2 | $3.45 | 102.9% |